Active, not recruitingNCT06936813
The PROMISE Survey
Studying Pituitary tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Basel, Switzerland
- Principal Investigator
- Cihan AtilaUniversity Hospital, Basel, Switzerland
- Enrollment
- 530 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- University Hospital Basel, Basel, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06936813 on ClinicalTrials.govOther trials for Pituitary tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07463235Safety and Potency of a High Cabergoline Dosage in MicroprolactinomasUniversity of Sao Paulo General Hospital
- ENROLLING BY INVITATIONEARLY PHASE1NCT07254104Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary TumorsPeking Union Medical College Hospital
- RECRUITINGPHASE2NCT06471829A Trial of Lu AG13909 in Adult Participants With Cushing's DiseaseH. Lundbeck A/S
- RECRUITINGPHASE2NCT06295952A Study of Pasireotide in People With ProlactinomaMemorial Sloan Kettering Cancer Center
- RECRUITINGNANCT06472505Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid LeakageNational Taiwan University Hospital
- RECRUITINGNCT06015802Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine TumorsSun Yat-sen University
- RECRUITINGNANCT05659524Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary SurgeryLori Wood
- RECRUITINGNCT00599092Pituitary Tumor Surveillance: Pathogenic CorrelationCedars-Sinai Medical Center